+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "JAK Inhibitor"

Janus Kinase (JAK) Inhibitors Global Market Report 2024 - Product Thumbnail Image

Janus Kinase (JAK) Inhibitors Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Janus Kinase (JAK) Inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Janus Kinase (JAK) Inhibitors - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
From
Tofacitinib Global Market Report 2024 - Product Thumbnail Image

Tofacitinib Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Psoriatic Arthritis Treatment Global Market Report 2024 - Product Thumbnail Image

Psoriatic Arthritis Treatment Global Market Report 2024

  • Report
  • February 2024
  • 250 Pages
  • Global
From
Crohn's Disease (CD) Treatment Global Market Report 2024 - Product Thumbnail Image

Crohn's Disease (CD) Treatment Global Market Report 2024

  • Report
  • January 2024
  • 175 Pages
  • Global
From
Rheumatoid Arthritis Drugs Global Market Report 2024 - Product Thumbnail Image

Rheumatoid Arthritis Drugs Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Tofacitinib Global Market Opportunities and Strategies to 2032 - Product Thumbnail Image

Tofacitinib Global Market Opportunities and Strategies to 2032

  • Report
  • January 2024
  • 244 Pages
  • Global
From
From
From
From
From
Vitiligo - Pipeline Insight, 2024 - Product Thumbnail Image

Vitiligo - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
Graft versus host disease - Pipeline Insight, 2024 - Product Thumbnail Image

Graft versus host disease - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 220 Pages
  • Global
From
Loading Indicator

The JAK Inhibitor market is a subset of the larger Immune Disorders Drugs market. JAK Inhibitors are a type of drug used to treat a variety of immune-related disorders, such as rheumatoid arthritis, psoriasis, and Crohn's disease. These drugs work by blocking the activity of Janus kinase (JAK) enzymes, which are involved in the body's inflammatory response. JAK Inhibitors are typically taken orally, and are often used in combination with other medications. The JAK Inhibitor market is highly competitive, with a number of large pharmaceutical companies vying for market share. Some of the major players in the market include AbbVie, Pfizer, Novartis, and Johnson & Johnson. Other companies, such as Celgene, Merck, and Eli Lilly, are also active in the market. Show Less Read more